Skip to main content
logo
Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
10.62
+0.27 (2.61%)
At close: Sep 18, 2026, 4:00 PM EDT
10.63
+0.01 (0.09%)
After-hours: Sep 18, 2026, 7:30 PM EDT

Immunic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
14564906862251
Market Cap Growth
77.04%-28.73%33.02%9.04%-75.28%-20.70%
Enterprise Value
-1030329-10142
Last Close Price
10.625.3410.0015.0014.0095.70

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
1.14-9.624.892.340.551.98
P/TBV Ratio
1.14-4.892.340.552.67

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.00-0.090.050.050.010.01
Net Debt / Equity Ratio
-1.212.23-1.88-1.57-1.01-0.68
Net Debt / EBITDA Ratio
1.310.140.350.461.331.16
Net Debt / FCF Ratio
1.760.170.410.641.761.03
Quick Ratio
4.970.641.641.999.107.81
Current Ratio
5.050.751.772.129.639.21
Return on Equity (ROE)
-138.17%-1653.15%-424.44%-131.28%-100.01%-65.02%
Return on Assets (ROA)
-66.80%-198.76%-128.79%-68.13%-40.53%-30.30%
Return on Capital Employed (ROCE)
-92.20%1572.20%-524.50%-335.60%-75.40%-58.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-76.99%-151.37%-111.58%-138.24%-193.89%-37.00%
FCF Yield
-60.76%-133.91%-94.39%-105.09%-105.08%-33.16%
Buyback Yield / Dilution
-156.51%-55.42%-126.03%-39.29%-34.52%-51.00%
SEC Filings: 10-K · 10-Q